Concepedia
Statistics
Publications
13
Citations
831
H-Index
12
Active since
1989
Affiliations
Institute for Cancer Prevention(Current)
Novartis (United States)
Dana (United States)
Novartis (Switzerland)
National Institutes of Health
Mark Kagan is an author at Institute for Cancer Prevention specializing in medicine, pharmacology, and analytical chemistry.
Top concepts
MedicinePharmacologyToxicologyAnalytical ChemistryDrug AnalysisTobacco ControlChromatographyMass SpectrometryChemistryBioanalysis
Publications per year
1989–2024
Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection
Klaus D. Brunnemann, Mark Kagan, Jonathan E. Cox et al. · Carcinogenesis · 1990 · 158 citations
Analytical Procedure, Chemistry, Cigarette Mainstream +21
Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers
Peter G. Foiles, Shobha A. Akerkar, Steven G. Carmella et al. · Chemical Research in Toxicology · 1991 · 122 citations
Dna Analysis, Tobacco Control, Gas Chromatography +18
Validation of biomarkers in humans exposed to benzene: Urine metabolites
Qingshan Qu, Assieh A. Melikian, Guilan Li et al. · American Journal of Industrial Medicine · 2000 · 120 citations
Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry
Assieh A. Melikian, Ray O’Connor, Agasanur K. Prahalad et al. · Carcinogenesis · 1999 · 100 citations · Full text
Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers.
Steven G. Carmella, Shashi S. Kagan, Mark Kagan et al. · PubMed · 1990 · 99 citations
Solvent Partitioning, Allergy, Biochemistry +15
1–5 of 13